Number of the records: 1  

Radium targets for cyclotron production of .sup.225./sup.Ac in view of targeted alpha therapy

  1. 1.
    SYSNO ASEP0579004
    Document TypeA - Abstract
    R&D Document TypeO - Ostatní
    TitleRadium targets for cyclotron production of 225Ac in view of targeted alpha therapy
    Author(s) Kellerbauer, A. (DE)
    Malmbeck, R. (DE)
    Carrpico De Almeida, C. (DE)
    Jajcisinova, E. (BE)
    Eloirdi, R. (DE)
    Lebeda, Ondřej (UJF-V) RID, ORCID, SAI
    Morgenstern, A. (DE)
    Number of authors7
    Source TitleEuropean Journal of Nuclear Medicine and Molecular Imaging. - : Springer - ISSN 1619-7070
    Roč. 50, Supplement 1 (2023), S11-S11
    Number of pages1 s.
    Publication formPrint - P
    ActionAnnual Congress of the European Association of Nuclear Medicine (ENAM'23)
    Event date09.09.2023 - 13.09.2023
    VEvent locationVienna
    CountryAT - Austria
    Event typeWRD
    Languageeng - English
    CountryUS - United States
    KeywordsAc-225 production ; radiology imaging ; alpha therapy
    OECD categoryRadiology, nuclear medicine and medical imaging
    Institutional supportUJF-V - RVO:61389005
    UT WOS001084059700010
    DOI10.1007/s00259-023-06333-x
    AnnotationTargeted alpha therapy using the radionuclide Ac-225 has shown remarkable beneft in clinical trials to patients sufering from various cancer types. Currently most Ac-225 is produced from a few sources of Th-229 existing worldwide. However, the total amount available is only sufcient for a few thousand patient doses. Given a projected demand that is several orders of magnitude higher, alternative paths for the production of Ac-225 must be developed. We have been investigating the route
    using the Ra-226(p,2n)Ac-225 reaction. It is particularly attractive due to its large cross-section near 17 MeV proton energy and because it can be readily employed at a large number of cyclotron facilities. The excitation function of this reaction has been previously measured by us for a few energies, but discrepancies with calculations remain. Hence, new irradiation experiments are required to improve the knowledge of the excitation function to support the industrial production of Ac-225 via this route.
    WorkplaceNuclear Physics Institute
    ContactMarkéta Sommerová, sommerova@ujf.cas.cz, Tel.: 266 173 228
    Year of Publishing2024
    Electronic addresshttps://doi.org/10.1007/s00259-023-06333-x
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.